| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| IOVANCE BIOTHERAPEUTICS, INC. | Chief Commercial Officer | Restricted Stock Units | 120K | $707K | $5.89 | Feb 10, 2025 | Direct |
| IOVANCE BIOTHERAPEUTICS, INC. | Chief Commercial Officer | Common Stock | 30K | $55.2K | $1.84 | Jun 5, 2025 | Direct |
| IOVANCE BIOTHERAPEUTICS, INC. | Chief Commercial Officer | Performance Stock Units | 150K | Feb 10, 2025 | Direct | ||
| IOVANCE BIOTHERAPEUTICS, INC. | Chief Commercial Officer | Stock Options (Right to Buy) | 35K | Feb 10, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| IOVA | IOVANCE BIOTHERAPEUTICS, INC. | Jun 5, 2025 | 1 | $55.2K | 4 | Jun 6, 2025 | Chief Commercial Officer |
| IOVA | IOVANCE BIOTHERAPEUTICS, INC. | Feb 10, 2025 | 3 | $0 | 4 | Feb 12, 2025 | Chief Commercial Officer |
| IOVA | IOVANCE BIOTHERAPEUTICS, INC. | Feb 10, 2025 | 0 | $0 | 3 | Feb 12, 2025 | Chief Commercial Officer |